ISBT 2022 Virtual Congress

Nafishah Ahmad

"Completed Post-Graduate Degree in Master of MEdicine (Transfusion Medicine) in 2011 Currently is the Head of Transfusion Medicine Department, Hospital Tengku Ampuan Rahimah (HTAR) Klang and State of Selangor Head of Transfusion Service since 02/01/2019 until present. Professional Experience Actively involved in Safe Transfusion Practice at Hospital and State levels Monitoring haemovigilance data and statistics at Hospital levels Monitoring customer satisfaction program in Transfusion Medicine, handling customer complaints and troubleshooting of problems. Involved in training nurses, house officers and Medical Laboratory Technicians (MLT) through CMEs and hands-on program held at Hospital and State levels Manage and verify reports for incidences such as transfusion reactions, donor adverse reactions, antibody cases and Cross-matching problems. Monitoring RCPA program for Immunohaematology Unit at the department "

---

Nor Hafizah Ahmad

Dr. Nor Hafizah Ahmad is a Transfusion Medicine Specialist who is currently the Head of Clinical Transfusion Division in National Blood Centre, Kuala Lumpur, Malaysia heading both National Immunohematology Reference Laboratory and Clinical Transfusion Section. She graduated from University Science Malaysia in year 2004 and completed her specialist training in M.Med Transfusion Medicine in year 2013 from Advanced Medical Dental Institute, USM. She has completed her subspecialty training in Patient Blood Management/Clinical Transfusion and Immunohematology in Sweden recently and has been regularly involved in conducting training around the country for many years in both areas. She has been appointed as the chairperson for National Rare Donor Program and is actively involved in the implementation of Patient Blood Management and Massive Transfusion Protocol in her place. She is involved as the secretariat for National Patient Blood Management Committee and also an active member of Malaysian Blood Society of Transfusion. She has also been invited as speaker in various conferences at local and national level in the field of Clinical Transfusion Immunohematology.

---

Cathy Balding

Cathy works with acute, community and aged care boards, executives and leaders to make quality make sense; specialising in purposeful and strategic clinical governance systems that focus on achieving a consistently high quality point of care and service experience for staff and consumers. She is the author of three books on this topic and has conducted published research into characteristics of effective quality and clinical governance systems. Cathy has developed quality and clinical governance frameworks, and associated tools and training, for Departments of Health and many aged, community and healthcare services. She was a healthcare executive, policymaker and accreditation assessor for two decades before starting her consulting business 15 years ago. As QualityworksPL, Cathy provides a suite of quality and clinical governance tools and training via her website, including the No Harm Done podcast.

: https://www.cathybalding.com/
: cathybalding
: @CathyBalding

---

Behnaz Bayat

Academic Curriculum Vitae / Employment:

2010-2014: Postdoctoral fellow in immunohematology laboratory of the institute for clinical immunology and transfusion medicine, Justus Liebig University, Giessen, Germany

2014-Present: The Head of the Research Laboratory and diagnostic fellow at granulocyte and immunohematology laboratories of the institute for clinical immunology and transfusion medicine, Justus-Liebig-University Giessen, Germany

2015-Present: Teaching the immunology course for medical students, Justus-Liebig-University Giessen, Germany Functions in scientific societies and institutions: Chairperson of International Working Party on Granulocyte Immunobiology, International Society for Blood Transfusion (ISBT) Member of the German Society for Transfusion Medicine and Immunohematology Advisory Member, International Working Party on Granulocyte Immunobiology, International Society for Blood Transfusion (ISBT)

Work experience:

2010 - Present: Working as a research and diagnostic fellow at platelet and granulocyte immunohematology of Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University Giessen, Germany 2

015 Present: Teaching the immunology course for medical students, Justus-Liebig-University Giessen, Germany

2007 - 2010: Worked as Ph.D. student at Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig University Giessen, Germany

2005 - 2007: Medical genetic Lab leader at the Medical Department of National Institute for Genetic Engineering Biotechnology, Tehran, Iran

1999 - 2005: Research assistant at the Genetic Department National

: behnaz-bayat-a3658ab0

---

Lilian Antwi Boateng

Dr. (Mrs.) Lilian Antwi Boateng is an early career lecturer and researcher in the haematology and immunohematology Unit of the Kwame Nkrumah University of Science and Technology, Ghana since 2012. she supervises and undertakes research specialising in blood transfusion and red blood cell antigens and alloantibodies Lilian holds a PhD in blood transfusion from the University of Liverpool. She holds Master and Bachelor of Science degrees in Biomedical Science from the University of Westminster, United Kingdom and Bachelor of Medical Laboratory Technology from Kwame Nkrumah University of Science and Technology, Ghana respectively. She also undertook a six months residency programme in blood banking at the University of Michigan and the University of Michigan blood bank reference laboratory as a fellow of the University of Michigan African Presidential Scholars Programme (UMAPS). Lilians aspiration in the long term is to progress professionally as a national and international transfusion research leader.

---

Thierry Burnouf

Thierry Burnouf, PhD, is Distinguished Professor and Vice-Dean of the College of Biomedical Engineering, Taipei Medical University, Taiwan. He is also Director of the International PhD Program in Biomedical Engineering and Professor at the Graduate Institute of Biomedical Materials and Tissue Engineering. For ISBT, Thierry acts as the Treasurer of the Working Party on Cellular therapies (chair: Mickey Koh), the Secretary of the Working Party on Global Blood Safety (chair: Martin Smid), and as a member of the Working Group on COVID-19 Convalescent Plasma Working transfusion subgroup (chair: Arwa Al-Riyami). His current field of research interest focuses on bioengineering and bioprocessing of virally-safe human platelet growth factor preparations (human platelet lysates) and blood cell-derived extracellular vesicles for regenerative medicine, cell therapy, and drug delivery. Previously Dr Burnouf has been the Director of Research and Development and Production Director of the plasma fractionation center at the Regional Blood Transfusion Center (Lille, France) and the Scientific Director of LFB (Laboratoire Franais du Fractionnement et des Biotechnologies, Les Ulis, France). Dr. Burnouf is an informal advisor of WHO on quality and safety of blood products and access to safe plasma products in low- and middle-income countries. Recently he chaired the drafting group of WHO Guidance on increasing supplies of plasma-derived medicinal products in low- and middle-income countries through fractionation of domestic plasma".Thierry has published over 280 articles and book chapters related to plasma fractionation and blood

---

Stuart Chesneau

No bio provided

: stuart-chesneau-16a2364

---

Juan Manuel Cisneros Carrasco

No bio provided

---

Laura Cooling

Dr. Cooling received a BS Microbiology, MS Pathology and MD from the University of Iowa, followed by residency training in clinical pathology and transfusion medicine/blood banking at the University of Iowa Hospitals, USA. During her residency and training, she did extensive research in the area of platelet and red cells glycosphingolipids, including studies in parvovirus B19 and shiga toxin-related disorders. She is currently a Professor of Clinical Pathology at the University of Michigan, serving as Associate Medical Director of Transfusion Medicine, Director, Immunohematology Reference Laboratory and Director, Cellular Therapy Laboratory. She has been active in ASFA, ICII and AABB for many years, serving on multiple committees including Chair of the AABB Education Committee, AABB Annual Meeting Committee, ASFA Clinical Applications Committee and ASFA HPC Committee.

---

Thane Moze Darumalinggam

Professional in Transfusion Medicine field, currently serving as Transfusion MedicineSpecialist in National Blood Centre, Kuala Lumpur. Over 12 years of experience intransfusion service and blood banking aspects. Presented many oral and poster presentationboth locally and internationally including ISBT. Contributed to several publications associated to blood donors.Also involved in active counselling and staff management pertaining to both professional and personal issues.Other key areas of interest includes blood procurement, understanding psychology of donors with donor care,medico-legal aspect, quality management system and patient blood management. Involved in giving lecturesfor students associated to transfusion service and post basic courses of Social Sciences. Fields handled under social sciences are motivation and team work. Effective communication and self-development.

---

Dana Devine

Dana Devine is currently the Chief Scientist at Canadian Blood Services. She is also the Director of the Centre for Blood Research and Professor of Pathology and Laboratory Medicine at the University of British Columbia. She was formerly the Chief Medical and Scientific Officer at Canadian Blood Services. In service to the transfusion community, Dr. Devine is a member of numerous advisory committees and boards including the American Red Cross, Vitalant Research Institute, Bloodworks Northwest, the New York Blood Center, the National Health Service Blood Transplant (UK) and the Australian Red Cross Blood Service. She served a nine year term as the Editor-in-Chief of the blood transfusion journal Vox Sanguinis. She is president of the AABB board of directors. Dr. Devine completed her research training at Duke University in North Carolina where she obtained the Ph.D. degree. She has a longstanding research career in blood products, transfusion medicine, platelet biology, complement biochemistry, and coagulation. Her research is funded by the Burroughs Wellcome Fund, Canadian Blood Services, Canadian Institutes of Health Research (CIHR) and the National Science and Engineering Research Council (NSERC). She is a fellow of the Canadian Academy of Health Sciences.

---

Maria Didriksen

I have a master's degree in Science of Public Health from University of Copenhagen, Denmark. Since 2016 I have been working as a research at the department of Clinical immunology, Copenhagen University Hospital, Rigshospitalet, where I am a part of the Dansich Blood Donor Study. Currently, I am finishing my ph.d. thesis. I mainly do epidemiological research that revovles around donor health. My research focuses mainly on neuropsychiatric disorders, particularly with a focus on sleep, restless legs syndrome, and depression causes and consequences hereof.

---

Saliou Diop

Saliou Diop is a Professor on Hematology and Blood Transfusion in Cheikh Anta Diop University (Dakar, Senegal) and Director of the national blood transfusion services in Senegal. He laso have great experience on hemophilia and inherited bleeding disorders as he's actually member of the World Federation of Hemophilia (WFH) Board of Directors and serve as Africa Regional adviser for WFH.

---

Marie-Pier Domingue

Marie-Pier Domingue is a Master student in Statistics at the University of Sherbrooke in Québec Canada

---

Abigail Edwards

In 2019, Abigail graduated from the University of Queensland with a Bachelor of Science (honours) in the field of Psychology. Her honours research assessed unique question-based interventions for blood donor recruitment and retention, as well as the underlying emotional motivations. in 2021, Abigail began her phd at the University of Queensland under the helping the medical matchmakers: sustaining and understanding living donors research program.

Abigail’s current program of research assesses the impact of identifying as a blood donor on future intentions to donate blood. Her research falls within applied social psychology, a field which focuses on implementing social psychology theory to enact real world change.

---

Peter Flanagan

Peter Flanagan has worked for New Zealand Blood Service for over 20 years and has played a key role in the establishment of a national blood service. He has a particular focus on blood safety and quality systems. He is currently the Chair of the ISBT Standing Committee on Ethics. He has been the President of the Australian and New Zealand Society of Blood Transfusion and of the International Society of Blood Transfusion. He is a member of the WHO Expert Panel for transfusion medicine.

---

Yoke-Lin Fung

Lin FUNG is the Associate Professor in Medical Laboratory Science at the University of the Sunshine Coast (USC) where she lectures in blood banking and transfusion science, and haematology. She is the leader of the OptiBlood research team at USC, where research projects are focussed on optimising the patients own blood resource and the effective use of blood products. Some of her key areas of interest are neutrophil immunobiology and transfusion-related acute lung injury (TRALI) blood donors and donation practices in the Asia Pacific blood management and blood use in older adults blood management and use in cardiac surgery, major abdominal surgery and orthopaedic surgery Many of these projects are conducted by health professionals completing part-time MSc of PhD studies to address question/problems relevant to their work. These are only possible through close collaboration with local and international clinical colleagues.

---

Cedric Ghevaert

Prof Ghevaert holds the Chair of Transfusion Medicine at the University of Cambridge and is a Consultant Haematologist for the NHS Blood and Transplant. His academic research group is based in the Wellcome-MRC Cambridge Stem Cell Institute in Cambridge, UK. He obtained his MD in 1998 from the University Libre de Bruxelles. After qualifying as a Consultant Haematologist, he did his PhD in Cambridge to develop recombinant antibodies for the treatment of fetomaternal alloimmune thrombocytopenia which culminated in a first-in-man study. Upon obtaining his PhD, Dr Ghevaert obtained a personal fellowship from the British Heart Foundation to work on megakaryopoiesis in the context of myeloproliferative diseases at the university of Birmingham. He was appointed as a Principal Investigator at the University of Cambridge in 2010. His current group focuses its work on the production of blood cells from pluripotent stem cells with the declared aim to produce novel cellular therapies for transfusion to patients. His approach combines the manipulation of key transcriptional regulators to efficiently forward programme stem cells into mature blood cells and 3D bioengineered scaffolds to recreate the bone marrow niche and increase the production efficiency and purity of the manufactured blood cells. His expertise lies at the hinge of basic bench-based science and translational studies."

---

Mindy Goldman

Dr. Goldman is a clinical hematologist with a fellowship in Transfusion Medicine. She has been active in many facets of transfusion medicine in Canada, including optimization of the donor screening process to ensure donor and recipient safety. She has contributed to assessment and implementation of blood donor criteria and policy changes. She is currently the Medical Director of Donor and Clinical Services at Canadian Blood Services.

---

Shane Grimsley

Working at the International Blood Group Reference Laboratory, NHSBT since 2009, as laboratory manager from 2015 and Senior Clinical Scientist since 2020, I have had the pleasure to help identify new blood group systems, new antigens and novel alleles. As well as helping lead a team of skilled and passionate scientists to resolve the worlds most complex immunohaematology cases, I have been able to contribute to ground-breaking projects that have improved the standards of care for patients.

---

Nancy Heddle

Professor Emeritus in the Department of Medicine, McMaster University

Nancy is currently a Professor Emeritus in the Department of Medicine at McMaster University and the Research Director at the McMaster Centre for Transfusion Research. She has published over 225 scientific papers and given more than 260 presentations nationally and internationally. Nancy trained as a Medical Laboratory Technologist.

She completed a Masters degree in Health Research Methodology at McMaster University in 1992 and set up a clinical research program in Transfusion Medicine at McMaster University in 2001. Her research has utilized both qualitative and quantitative methodologies with a focus on evidence-based and safe transfusion practices. Throughout her career she has been an educator, a researcher and a mentor, teaching transfusion science and research methodology to over 250 fellows, residents, graduate students and medical laboratory technologists. A teaching award in her name was created by the Division of Hematology at McMaster University and is given annually to a faculty member who demonstrates excellence in teaching.

Nancy served as an Associate Editor for the journal Transfusion from 2004 to 2018 and initiated the Clinical Research Focus section for the journal as a resource to understand clinical research methodology.  She has received 18 national and international awards including the International Woman in Transfusion Award (AABB, BBTS and ISBT), the Emily Cooley Award from the AABB and a Lifetime Achievement Award from Canadian Blood Services.

---

Christine Henny

2016 - today    Group Leader, R&D Blood Group Diagnostics and Swiss National reference laboratory for Immunohematology Interregional Blood Transfusion SRC, Bern, Switzerland 

2013-2016     Senior Scientist,R&D Blood Group Diagnostics and Swiss National reference laboratory for Immunohematology Interregional Blood Transfusion SRC, Bern, Switzerland 

2011-2013    Postdoctoral Scientist, R&D Blood Group Diagnostics and Swiss National reference laboratory for Immunohematology Interregional Blood Transfusion SRC, Bern, Switzerland

---

Jin-Sung Jang

2000~2006: Chonnam national university medical school, Gwangju, Korea

2007~2010: Boeun public health center, Boeun, Korea

2011~2022: Korean Red Cross Blood Services, Wonju, Korea

---

Mart Janssen

Mart Janssen, studied Mechanical Engineering at the Technical University Eindhoven after which he worked as a Risk Reliability engineer and Risk Management Consultant for eight years. In 2002 he switched to the University Medical Center Utrecht doing research in the field of Medical Technology Assessment. Since 2004 he has been working on blood transfusion related risk- and technology assessment studies for Sanquin, where in 2012 he became head of the Transfusion Technology Assessment group. 

---

Wooi Seong Kam

Wooi Seong is the Assistant Group Director (Blood Supply) of the Blood Services Group at Health Sciences Authority (HSA), Singapore. He oversees the Blood Resources Division and Blood Supply Management Division, which are responsible for the collection, processing, testing and distribution of blood products to all hospitals in Singapore. The HSAs Blood Services Group runs the National Blood Program. Its mission is to secure the nation's blood supply by ensuring a safe and adequate blood supply.

---

Rick Kapur

No bio provided

---

Jan Karregat

I am third year phd candidate who works at the dutch blood bank, sanquin. i have a background in biomedical science and i'm currently finishing a masters in epidimiology. for my phd trajectory i’m working on a project aimed at iron supplementation as a blood bank policy.

---

Thomas Klei

With his research, Thomas Klei focusses on red blood cell and platelet turnover in health and disease. Currently he is managing a research group that strives to improve quality of existing- and develop novel blood products and is directing implementation through clinical evaluation.

---

Pawinee Kupatawintu

Pawinee Kupatawintu obtained her bachelors degree in medical technologist from Chulalongkorn University and masters degree in medical Technologist from the Mahidol University. She has been working at National Blood Center since 1989. She had experiences in apheresis and red cell serology. She has been involved great skill in platelet antibody, HLA, bone marrow cryopreservation and unrelated stem cell donor registry fields for 16 years. She had been promoted to be assistant director of National Blood Centre, Thai Red Cross Society from 2016 to 2017 and currently being deputy director since 2018.

---

So-Yong Kwon

From July 2019 ro present, the Director of the Blood Safety Bureau at the Headquarters of the Korean Red Cross Blood Services

---

Cheuk Kwong Lee

Dr Lee is currently the Chief Executive and Medical Director of the Hong Kong Red Cross Blood Transfusion Service. He received his undergraduate and medical training at the University of Hong Kong and became specialist in Haematology and Haematological oncology at the Queen Mary Hospital, the University of Hong Kong, Hong Kong. After 8 years of clinical work, he moved to Hong Kong Red Cross Blood Transfusion Service where he became the head of Blood Collection and Donor Recruitment Department. Apart from his role in securing safe and adequate blood supply to patients in Hong Kong, Dr Lee is also the head of Hong Kong Bone Marrow Donor Registry which provide unrelated haematopoietic stem cells to patients undergoing transplantation. Dr Lee has developed interest at transfusion microbiology and donor health and medicine. He has made extensive contribution in understanding and implementing preventive measure in minimizing transfusion transmitted bacterial sepsis. Besides, as healthy and committed donors are success to the blood service, Dr Lee has been actively involved in studies to understand and minimize donation related vasovagal reaction and donors haemoglobin and iron. Recently, he and his team are actively working to increase the awareness and knowledge of the territory on Blood Supply, Blood Transfusion and Patient Blood Management.

---

Shui Shan Lee

Dr Lee is a clinician and specialist in internal medicine, immunopathology and public health. He joined The Chinese University of Hong Kong in 2005 and was awarded Daniel Yu Professorship in 2018. His is currently Research Professor and Deputy Director of the Universitys Stanley Ho Centre for Emerging Infectious Diseases. Between 1991 and 2005, Dr Lee headed the Hong Kong Governments AIDS programme, during which he directed the territorys HIV prevention, control and treatment services. He is the Founding President of Hong Kong Society for HIV Medicine, and has been chairman of Scientific Committee on AIDS and STI of the Governments Centre for Health Protection since 2016. He is an Associate Editor of International Journal of Infection Diseases, and Addiction. Dr Lee has, on various occasions, served as consultant to national and international organisations in the assessment of HIV situations, programme evaluations, and advise on harm reduction development. His major areas of research interest include biomedical approach to HIV prevention, infectious disease epidemiology, emerging infectious diseases. Dr Lee has authored over 250 peer-reviewed articles, 40 book chapters, and is the editor of the HIV Manual in Hong Kong.

---

Carol Lim

Dr. Carol KK Lim is a Maternal Fetal Medicine Consultant serving in a major public hospital in Malaysia. Her interest includes community obstetrics and she believes health system improvement is key to better maternal and neonatal health. Beside obstetric venous thromboembolism, maternal anemia is the other major area of interest of hers. For the same reason, she has been a vocal advocate and champion for Patient Blood Management (PBM) in her hospital and in Malaysia, as PBM is the key to managing anemia.

---

Tang Yee Loong

Dr. Tang is a medical lecturer working in the Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM). He is also a consultant haematologist working in the Department of Diagnostic Lab Service and the head of the Blood Bank unit, hospital UKM. He actively participates in many academic activities and currently serves as the reviewer of medical specialist CPD points in the Malaysian Medical Council, webmaster, and committee in College of Pathologists, Academy Medicine of Malaysia as well as a life member of the Malaysian Society of Haematology. He has completed the visitor training program organised by the American Society of Haematology at the prestigious Emory University Hospital in the year 2018. His current research mainly focused on haematological disorders and transfusion medicine.

---

Genghis Lopez

Dr Genghis Lopez is a Senior Scientist at the Australian Red Cross Lifeblood in Brisbane, Australia. Currently, he is a part of the Transfusion Science Research team that investigates complex blood group molecular variants. Prior to this role, he worked at Lifebloods Platelet and Granulocyte Reference Laboratory and the Red Cell Reference Laboratory. He is a member of the Australian New Zealand Society of Blood Transfusion and the ISBT.

---

Jessie S. Luken

Jessie Luken (MD) works as consultant in Transfusion Medicine and Immunohaematology Diagnostics at Sanquin Diagnostic services in Amsterdam. She works at Sanquin for 12 years.

---

Joy John Mammen

Joy Mammen MBBS, MD, did his medical training at the Christian Medical College (CMC) Vellore, followed by a Fellowship in Pathology Informatics in the USA. He is working in CMC since 1999, and currently heads the Department of Transfusion Medicine and is also an Associate Director there. His areas of interest include lab haematology, information management, voluntary blood donors, policy, and public health aspects of Blood Transfusion Service. He is an expert advisor to the National and State Blood Transfusion Services in India. He is a consultant to WHO SEARO in the same domain. He also serves on the board of directors of ICCBBA, an organization responsible for the global standard for medical products of human origin (ISBT128).

---

Denese Marks

A/Prof Marks has led the Product Development research team since 2008. She holds an adjunct appointment with the School of Medicine at the University of Sydney. Denese received her PhD from the University of Technology, Sydney in 1995. She has held post-doctoral fellowships at the University of Vienna, the University of Melbourne and Great Ormond Street Hospital in London. A/Prof Marks current research focuses on improving blood processing technologies and component storage, including platelet cryopreservation, investigating donor attributes that may influence blood component quality, and clinical trials of new blood products. She has over 100 peer-reviewed publications, and is a section editor for the Vox Sanguinis journal. She has leadership roles as a scientific member of the Conventional Components Team in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, the Chair of the ISBT Blood Compnents Working Party and as a member of the ISBT Board of Directors. She currently holds grants from NHRMC, ARC, ANZSBT and the MRFF.

---

Yuyun Maryuningsih

Yuyun Siti Maryuningsih, Team Leader for Blood and other Products of Human Origin, Technical Standard and Specifications Unit, Health Products Policy and Standards Department, WHO Headquarter Specialty: Medical Doctor with specialization in Transfusion Medicine and a doctorate in Biomedical Sciences Education and Academic Career : 2010: PhD- Biomedical Science, Indonesian University, Indonesia 1996: Master's degree - Virology, Adelaide University, Australia 1988: Medical degree - Padjadjaran University, Indonesia Work Experience: Oct 2018-Now, WHO headquarters 2015-2018, Blood Services Program Coordinator at the Directorate of Primary Health Services within the Ministry of Health of Indonesia 2011-2018, Coordinator of the Master Program on Biomedics Specialty in Transfusion Science at Indonesian University 2004-2015, Director of the Central Blood Transfusion Service at the Indonesian Red Cross Affilation and membership: 2015-2017, Chairperson of the Indonesian Association of Transfusion Medicine (PDTDI) 2016-2019, Regional Director of the International Society of Blood Transfusion (ISBT) for South East Asia Region. 2015, Committee Member of Partnership Training Network of APEC Blood Supply Chain Forum 2005-2020, Member of the International Society of Blood Transfusion (ISBT) 2017-2019, Chairman for Indonesian National Blood Services Committee

---

Hanke Matlung

Hanke Matlung, PhD, was recently appointed by Sanquin to build and continuate diagnostics and research related to iron metabolism and disorders at Sanquin Iron Expert Center. This will benefit patients with iron disorders in general and health of donors and patients receiving blood products in particular. Before focusing on the field of iron disorders, she has 10 years of fundamental research experience in the field of phagocyte effector functions within the Phagocyte Laboratory at Sanquin.

---

Ryan A Metcalf

Dr. Metcalf is Section Chief of Transfusion Medicine, Medical Director of the Transfusion Service, Associate Professor of Pathology, and Inpatient Chief Value Officer for the Department of Pathology at the University of Utah Health and ARUP Laboratories. He completed a residency in Anatomic and Clinical Pathology and a fellowship in Transfusion Medicine at Stanford University. Dr. Metcalf practices transfusion medicine and his specific interests include data-driven/informatics approaches to patient blood management, quality management, and innovation. His research interests include the use of machine learning to predict patient blood management outcomes, data visualization to identify root causes from complex clinical data, and data-driven approaches to improve our understanding of risks associated with blood transfusion. Dr. Metcalf is Chair-Elect of the AABB Clinical Transfusion Medicine Committee, a member of the AABB Patient Blood Management Standards Committee, and a member of the College of American Pathologists (CAP) Transfusion, Apheresis, and Cellular Therapy Committee.

---

Aline Mirrione Savin

No bio provided

---

Rachel Moss

Transfusion Practitioner, Great Ormond Street Hospital, London

No bio provided

: @Rachmosshibb

---

Idaleswati Nor Mohamed

Dr. Idaleswati Nor Mohamed is a haemovigilance specialist with a special interest in blood safety and quality regulation. She works at the National Blood Centre in Kuala Lumpur as a Transfusion Medicine Specialist and the chief of the National Surveillance and Assessment Department. Dr. Nor Mohamed is dedicated to blood safety and developing the best strategies for donors and recipients. Bringing forth an empathic and professional approach, dedicated to offering the best possible treatment to patients. A competent leader who collaborates well with colleagues in the medical field.

---

Shirley Owosu

No bio provided

---

David Peterson

David is a transfusion medicine scientist and educator. He is currently the manager of BloodSafe e-learning Australia, an e-learning program funded by all states and territories of Australia to improve clinical transfusion practice by doctors, nurses, midwives and other healthcare staff involved in the transfusion chain across Australia

---

Franke Quee

I'm a researcher with a background in biomedical sciences and epidemiology. the main focus of my research is blood donor health and blood donor behaviour. recently i started a phd trajectory focussing on the blood donor as sentinel for emerging infections. currently the majority of the work focusses on sars-cov-2 antibody testing in blood donors.

---

Elisabeth Semple

Dr Semple recieved her PhD in cell biology from the University of Linkping, Sweden. After specializing in production and storage of blood components, especially leuko-reduction and production of platelet concentrates, she moved on to stem cells and now to monoclonal antibodies. She has held leadership positions in the hospital and not-for-profit settings, in academia and in industry for over 35 years. After almost 20 years in North America, working in both Canada and the USA, she has returned to Sweden and is now Director of the Quality Control (QC) department at BioInvent International in Lund.

---

John Semple

No bio provided

---

Martin Smid

Martin Smid (1958, Netherlands, MD Medicine, PhD and MBA) has more than 25 years experience in blood bank management, transfusion medicine and coagulation. He is managing director of Sanquin Consulting Services and the Academic Institute IDTM. He is chair of the ISBT WP GBS since 2018 and member from the start in 2010. After the position of the WP was settled the focus is to make challenges for availability and safety of the blood supply globally and develop solutions to improve the situation in limited resource countries visible for ISBT membership. Martins main responsibilities include international cooperation and knowledge sharing in international projects and the Management of Transfusion Medicine programme at the Graduate School of Medical Science of the University of Groningen. He has contributed to projects in over 20 countries globally and is involved in the WHO Global Blood Safety Network and AfSBT Educational Committee and also is an advisor of the Curacao blood bank. He has over 50 publications in transfusion, hemophilia and coagulation. 

---

Jill Storry

Jill Storry is Professor of Experimental Transfusion Medicine at the Division of Haematology Transfusion Medicine, Department of Laboratory Medicine, Lund University (LU), Sweden, and also responsible for the Immunohematology laboratories within the Department of Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Lund. Primary areas of interest are the study of human blood group systems, both from a clinical perspective in the provision of providing blood to alloimmunised patients and from the perspective of human polymorphism, and its role in health and disease. Her research focus is the investigation and characterisation of erythrocyte membrane glycoproteins carrying blood group polymorphisms, their function and interaction with pathogens, e.g. malarial parasites. Jill is a member of the Editorial Boards of Transfusion Medicine Reviews, Transfusion and Immunohematology, Section Editor for Vox Sanguinis and a peer reviewer for these and other scientific journals. She is a member of the ISBT Working Parties on Red Cell Immunogenetics and Red Cell Nomenclature, and Rare Donors.

---

Jarkko Toivonen

The author got his phd in compute science in year 2019 from the university of helsinki, finland. since then he has worked at the finnish red cross blood service, doing blood donor health related research.

---

Teguh Triyono

Dr Teguh Triyono graduated from Doctoral Program of Universitas Gadjah Mada Yogyakarta Indonesia. He has been worked as lecturer in Faculty of Medicine, Universitas Gadjah Mada, and the head of Dr Sardjito Hospital Transfusion Services for more than 15 years, with many publications. He recently active as the chairman of National Transfusion Committee, and a member of National Comittee of Patient Safety, as well as a member of the Advisory Group WHO on Blood Regulation-Availability-Safety.

---

Nelson Tsuno

1987: Graduated from the Faculty of Medicine, University of Sao Paulo (Brazil) 1995: Graduated from the Faculty of Medical Sciences, the University of Tokyo (Japan), and obtained the PhD 1996 - 2009: Assistant professor of the Department of Transfusion Medicine, the University of Tokyo 2010 - 2014: Lecturer and Vice-Director of the Department of Transfusion Medicine, the University of Tokyo 2015: Project Physician at Astrazeneca 2015 - 2017: Medical Director at Novartis Pharma Medical Headquarters 2017: Graduated in Master of Business Administration (MBA) from McGill University (MBA Japan course) 2017 - Present: Senior Director of the Laboratory Department, Japanese Red Cross Kanto-Koshinetsu Block Blood Center 2019 - Present: Visiting Associate Professor, Keio University, Center for Transfusion Medicine and Cell Therapy 2019 - Present: Deputy Director General, Japanese Red Cross Kanto-Koshinetsu Block Blood Center 2021: Associate Editor, ISBT Science Series 2022: Section Editor, Vox Sanguinis

---

John-Paul Tung

Senior Research Fellow, Australian Red Cross LifeBlood

No bio provided

---

Marion Vermeulen

Marion is the Executive: Transfusion Medicine and Technical Services at the South African National Blood service (SANBS). Her current role consists of the development of the SANBS strategy with direct responsibility for the testing, processing, issuing, transportation and logistics of 1 million donations per annum. Marion has been actively involved in research during her career with regards to TTIs and has published over 50 manuscripts. More recently Marion is the principle investigator for the PROTECT COVID19 Convalescent plasma donor and anti-SARS-COV-2 seroprevalence studies. In addition to these SANBS commitments, Marion also provides mentorship to young investigators in clinical research through the international society for blood transfusion (ISBT).

---

Alexander Vlaar

Professor Intensive Care Medicine, Amsterdam UMC

Alexander Vlaar. PhD, MD, MBA is professor Intensive Care Medicine (H-index: 31, 4.570 citation, > 220 articles) and principal investigator in intensive care medicine.

The focus of his research is transfusion-related morbidity and mortality. His research lines consist, among others, of pre-clinical and clinical investigation in the field of antibody and non-antibody mediated transfusion related acute lung injury (TRALI) and transfusion associated circulatory overload (TACO).

He is the chair of the international TRALI re-definition working group and chair of the ESICM Transfusion Task Force.

: alexander-vlaar-13a6338

---

Barbee Whitaker

Dr. Barbee Whitaker is a Lead Scientist in the Office of Biostatistics and Epidemiology within the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA). She is the FDA lead for the ADVANCE Study to explore expanded MSM behavioral risk questions for blood donation and FDA co-lead for the Transfusion Transmissible Diseases Monitoring System (TTIMS). Dr. Whitaker investigates biologics outcomes, including blood product safety, through adverse event reporting and Real World Evidence (RWE) using electronic health records. She is actively involved in design of systems to better capture these data for regulatory use. In collaboration with public and private sectors, Dr. Whitaker led the initial and ongoing development of hemovigilance programs in the US, focusing on data collection from hospitals and blood centers and providing useful and actionable information locally and nationally. Dr. Whitaker is on the Board of the International Haemovigilance Network.

---

Erica Wood

Head, Transfusion Research Unit, Monash University

Erica Wood is the president of ISBT, and a member of its working parties on clinical practice, haemovigilance, and transfusion-transmitted infectious diseases. From 2010-2014 she was ISBT regional director for the Western Pacific region.

Erica is head of the Transfusion Research Unit in the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, Australia. She is a consultant haematologist at Monash Health and holds an honorary appointment at the Peter MacCallum Cancer Centre. Erica is past president of the International Haemovigilance Network, past-president of the Australian and New Zealand Society of Blood Transfusion, and a member of the World Health Organization Expert Advisory Panel in Transfusion Medicine. Erica has served as Chief Examiner (Haematology) for the Royal College of Pathologists of Australasia and chair of the Joint Specialist Advisory Committee in Haematology.

She is a member of the Victorian Blood Matters program advisory committee and the expert group of its Serious Transfusion Incident Reporting (STIR) haemovigilance program. In 2013, Erica was awarded a Churchill Fellowship to support her practice and research in patient blood management.

: @erica_m_wood

---